June 27, 2026 New blood test detects 90% of aggressive prostate cancer cases, beating current screenings The Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.
June 17, 2026 Cure for certain cancers is ‘realistic’ goal in next decade, pharma lead says Johnson & Johnson CEO says the goal is to eliminate cancer in the next decade, citing progress in multiple myeloma and immunotherapy treatments.
June 13, 2026 Former wrestler, actor reveals breast cancer diagnosis: 'One in 750 men' Tyler Mane, known for "X-Men" and "Halloween," revealed his breast cancer diagnosis and begins chemo, raising awareness about the overlooked disease in men.
June 3, 2026 One extra serving of processed meat a day linked to higher cancer risk Processed meat consumption may be linked to an increased risk of stomach and esophageal cancer, according to a large European study spanning 14 years.
June 1, 2026 Veterans face surprising threat after cancer diagnosis, study reveals A new JAMA Oncology study finds veterans with cancer face elevated suicide risk that can persist for up to five years following their diagnosis.
May 28, 2026 What to know about thyroid cancer prognosis following Pam Bondi's diagnosis Former AG Pam Bondi was reportedly diagnosed with thyroid cancer after leaving the Justice Department. Here's what to know about the disease.
May 27, 2026 Doctors push new blood tests for colon cancer as cases surge in younger adults The American Cancer Society updated colorectal cancer screening guidelines, adding blood-based tests and reaffirming screening should begin at age 45.
May 26, 2026 Ozempic-style drugs linked to major slowdown in cancer spread, new study finds A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers, including lung cancer.
May 20, 2026 New drug approach offers hope for patients with recurrent aggressive cancers Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
May 18, 2026 New pancreatic cancer pill nearly doubles survival time in breakthrough trial A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.